BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37349548)

  • 1. Ethambutol and visual assessment in England: current practice and recommendations.
    MacVinish S; McMaster D; Moledina T; Tamne SK; Ashworth J; Anderson SR
    Eye (Lond); 2024 Jan; 38(1):112-117. PubMed ID: 37349548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethambutol-associated optic neuropathy.
    Lim SA
    Ann Acad Med Singap; 2006 Apr; 35(4):274-8. PubMed ID: 16710500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular ethambutol toxicity.
    Melamud A; Kosmorsky GS; Lee MS
    Mayo Clin Proc; 2003 Nov; 78(11):1409-11. PubMed ID: 14601701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethambutol-induced optic neuropathy.
    Kyncl M; Fus M; Lestak J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Sep; 167(3):288-293. PubMed ID: 35582729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea.
    Lee EJ; Kim SJ; Choung HK; Kim JH; Yu YS
    J Neuroophthalmol; 2008 Dec; 28(4):269-77. PubMed ID: 19145123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethambutol-induced optic neuropathy in renal disorder: a clinico-electrophysiological study.
    Kanaujia V; Jain VK; Sharma K; Agarwal R; Mishra P; Sharma RK
    Can J Ophthalmol; 2019 Jun; 54(3):301-305. PubMed ID: 31109468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethambutol and optic neuropathy.
    Chuenkongkaew W; Samsen P; Thanasombatsakul N
    J Med Assoc Thai; 2003 Jul; 86(7):622-5. PubMed ID: 12948256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of toxic optic neuropathy with low-dose ethambutol.
    Yang HK; Park MJ; Lee JH; Lee CT; Park JS; Hwang JM
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):261-4. PubMed ID: 26792482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced optic neuropathy-TB or not TB.
    Pradhan M; Sharp D; Best S; Vincent A; Vaphiades M
    Surv Ophthalmol; 2010; 55(4):378-85. PubMed ID: 20083290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy.
    Zoumalan CI; Agarwal M; Sadun AA
    Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):410-6. PubMed ID: 15565293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe and reversible optic neuropathy by ethambutol and isoniazid].
    Rodríguez-Marco NA; Solanas-Alava S; Ascaso FJ; Martínez-Martínez L; Rubio-Obanos MT; Andonegui-Navarro J
    An Sist Sanit Navar; 2014; 37(2):287-91. PubMed ID: 25189987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethambutol-induced optic neuropathy: Functional and structural changes in the retina and optic nerve.
    Sen S; Mandal S; Banerjee M; Gk R; Saxena A; Aalok SP; Saxena R
    Semin Ophthalmol; 2022 Aug; 37(6):730-739. PubMed ID: 35699333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy.
    Chai SJ; Foroozan R
    Br J Ophthalmol; 2007 Jul; 91(7):895-7. PubMed ID: 17215265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy.
    Saxena R; Singh D; Phuljhele S; Kalaiselvan V; Karna S; Gandhi R; Prakash A; Lodha R; Mohan A; Menon V; Garg R
    Indian J Ophthalmol; 2021 Dec; 69(12):3734-3739. PubMed ID: 34827033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optic nerve neuropathy by ethambutol toxicity].
    Chen L; Liang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):302-4. PubMed ID: 11775861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rare ethambutol-induced optic neuropathy: A case-report and literature review.
    Song W; Si S
    Medicine (Baltimore); 2017 Jan; 96(2):e5889. PubMed ID: 28079833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of visual functions in patients on ethambutol therapy for tuberculosis: a prospective study.
    Goyal JL; De Sarmi ; Singh NP; Bhatia A
    J Commun Dis; 2003 Dec; 35(4):230-43. PubMed ID: 15909750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of ethambutol-related visual impairment during treatment of active tuberculosis.
    Ezer N; Benedetti A; Darvish-Zargar M; Menzies D
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):447-55. PubMed ID: 23394767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?
    Kumar SR; Hissar SS; Ramesh PM; Shanmugam M; Kalaiselvan V; Prakash J; Padmapriyadarsini C
    Int J Tuberc Lung Dis; 2024 Jan; 28(1):51-53. PubMed ID: 38178302
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethambutol/Linezolid Toxic Optic Neuropathy.
    Libershteyn Y
    Optom Vis Sci; 2016 Feb; 93(2):211-7. PubMed ID: 26636399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.